Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study.

De Vriese AS, Caluwé R, Pyfferoen L, De Bacquer D, De Boeck K, Delanote J, De Surgeloose D, Van Hoenacker P, Van Vlem B, Verbeke F.

J Am Soc Nephrol. 2019 Nov 8. pii: ASN.2019060579. doi: 10.1681/ASN.2019060579. [Epub ahead of print]

PMID:
31704740
2.

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.

Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators.

Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Erratum in: Lancet. 2019 May 11;393(10184):1936.

PMID:
30995972
3.

Measurement of pulse wave velocity, augmentation index, and central pulse pressure in atrial fibrillation: a proof of concept study.

Caluwé R, De Vriese AS, Van Vlem B, Verbeke F.

J Am Soc Hypertens. 2018 Aug;12(8):627-632. doi: 10.1016/j.jash.2018.06.016. Epub 2018 Jun 30.

PMID:
30049625
4.

Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.

Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Perrone RD, Koch G, Ouyang J, McQuade RD, Blais JD, Czerwiec FS, Sergeyeva O; REPRISE Trial Investigators.

N Engl J Med. 2017 Nov 16;377(20):1930-1942. doi: 10.1056/NEJMoa1710030. Epub 2017 Nov 4.

5.

Effect of Magnesium Supplements on Insulin Secretion After Kidney Transplantation: A Randomized Controlled Trial.

Van Laecke S, Caluwe R, Huybrechts I, Nagler EV, Vanholder R, Peeters P, Van Vlem B, Van Biesen W.

Ann Transplant. 2017 Aug 29;22:524-531.

6.
7.

Dose-finding study of rivaroxaban in hemodialysis patients.

De Vriese AS, Caluwé R, Bailleul E, De Bacquer D, Borrey D, Van Vlem B, Vandecasteele SJ, Emmerechts J.

Am J Kidney Dis. 2015 Jul;66(1):91-8. doi: 10.1053/j.ajkd.2015.01.022. Epub 2015 Mar 21.

PMID:
25804678
8.

Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease.

Yale JF, Bakris G, Cariou B, Nieto J, David-Neto E, Yue D, Wajs E, Figueroa K, Jiang J, Law G, Usiskin K, Meininger G; DIA3004 Study Group.

Diabetes Obes Metab. 2014 Oct;16(10):1016-27. doi: 10.1111/dom.12348. Epub 2014 Jul 22.

PMID:
24965700
9.

Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study.

Caluwé R, Vandecasteele S, Van Vlem B, Vermeer C, De Vriese AS.

Nephrol Dial Transplant. 2014 Jul;29(7):1385-90. doi: 10.1093/ndt/gft464. Epub 2013 Nov 26.

PMID:
24285428
10.

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.

de Zeeuw D, Akizawa T, Audhya P, Bakris GL, Chin M, Christ-Schmidt H, Goldsberry A, Houser M, Krauth M, Lambers Heerspink HJ, McMurray JJ, Meyer CJ, Parving HH, Remuzzi G, Toto RD, Vaziri ND, Wanner C, Wittes J, Wrolstad D, Chertow GM; BEACON Trial Investigators.

N Engl J Med. 2013 Dec 26;369(26):2492-503. doi: 10.1056/NEJMoa1306033. Epub 2013 Nov 9.

11.

Dialysability of sugammadex and its complex with rocuronium in intensive care patients with severe renal impairment.

Cammu G, Van Vlem B, van den Heuvel M, Stet L, el Galta R, Eloot S, Demeyer I.

Br J Anaesth. 2012 Sep;109(3):382-90. doi: 10.1093/bja/aes207. Epub 2012 Jun 24.

12.

Translesional pressure gradients to predict blood pressure response after renal artery stenting in patients with renovascular hypertension.

Mangiacapra F, Trana C, Sarno G, Davidavicius G, Protasiewicz M, Muller O, Ntalianis A, Misonis N, Van Vlem B, Heyndrickx GR, De Bruyne B.

Circ Cardiovasc Interv. 2010 Dec;3(6):537-42. doi: 10.1161/CIRCINTERVENTIONS.110.957704. Epub 2010 Nov 15.

PMID:
21078879
13.

Simple assessment of patient's stage of chronic kidney disease using eGFR-MDRD nomograms.

Eloot S, Van Vlem B, De Meester J.

Int Urol Nephrol. 2012 Feb;44(1):207-12. doi: 10.1007/s11255-010-9849-x. Epub 2010 Oct 21.

PMID:
20963489
14.

Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial.

Carrera F, Lok CE, de Francisco A, Locatelli F, Mann JF, Canaud B, Kerr PG, Macdougall IC, Besarab A, Villa G, Kazes I, Van Vlem B, Jolly S, Beyer U, Dougherty FC; PATRONUS Investigators.

Nephrol Dial Transplant. 2010 Dec;25(12):4009-17. doi: 10.1093/ndt/gfq305. Epub 2010 Jun 3.

15.

C.E.R.A. safety profile: a pooled analysis in patients with chronic kidney disease.

Locatelli F, Mann JF, Aldigier JC, Sanz Guajardo D, Schmidt R, Van Vlem B, Sulowicz W, Dougherty FC, Beyer U.

Clin Nephrol. 2010 Feb;73(2):94-103.

PMID:
20129016
16.

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wüthrich RP, Gottlow M, Johnsson E, Zannad F; AURORA Study Group.

N Engl J Med. 2009 Apr 2;360(14):1395-407. doi: 10.1056/NEJMoa0810177. Epub 2009 Mar 30. Erratum in: N Engl J Med. 2010 Apr 15;362(15):1450.

17.

Tight perioperative glucose control is associated with a reduction in renal impairment and renal failure in non-diabetic cardiac surgical patients.

Lecomte P, Van Vlem B, Coddens J, Cammu G, Nollet G, Nobels F, Vanermen H, Foubert L.

Crit Care. 2008;12(6):R154. doi: 10.1186/cc7145. Epub 2008 Dec 4.

18.

Intravenous C.E.R.A. maintains stable haemoglobin levels in patients on dialysis previously treated with darbepoetin alfa: results from STRIATA, a randomized phase III study.

Canaud B, Mingardi G, Braun J, Aljama P, Kerr PG, Locatelli F, Villa G, Van Vlem B, McMahon AW, Kerloëguen C, Beyer U; STRIATA Study Investigators.

Nephrol Dial Transplant. 2008 Nov;23(11):3654-61. doi: 10.1093/ndt/gfn320. Epub 2008 Jun 27.

19.

End-stage disease of native kidneys in a patient with biopsy-proven Arndt-Gottron scleromyxoedema and recurrence in the transplanted kidney.

Peeters P, Praet M, Van Vlem B, Naeyaert JM, Vanholder R.

Nephrol Dial Transplant. 2007 Oct;22(10):3065-9. Epub 2007 Jul 5.

PMID:
17616537
20.

Preservation of renal function after heart transplantation: initial single-center experience with sirolimus.

De Meester JM, Van Vlem B, Walravens M, Vanderheyden M, Verstreken S, Goethals M, Kerre N, Wellens F.

Transplant Proc. 2005 May;37(4):1835-8.

PMID:
15919481
21.

Telomeric refinement of the MCKD1 locus on chromosome 1q21.

Wolf MT, van Vlem B, Hennies HC, Zalewski I, Karle SM, Puetz M, Panther F, Otto E, Fuchshuber A, Lameire N, Loeys B, Hildebrandt F.

Kidney Int. 2004 Aug;66(2):580-5.

22.

Urinary excretion of the uraemic toxin p-cresol in the rat: contribution of glucuronidation to its metabolization.

Lesaffer G, De Smet R, Belpaire FM, Van Vlem B, Van Hulle M, Cornelis R, Lameire N, Vanholder R.

Nephrol Dial Transplant. 2003 Jul;18(7):1299-306.

PMID:
12808165
23.

Reevaluation of formulas for predicting creatinine clearance in adults and children, using compensated creatinine methods.

Wuyts B, Bernard D, Van den Noortgate N, Van de Walle J, Van Vlem B, De Smet R, De Geeter F, Vanholder R, Delanghe JR.

Clin Chem. 2003 Jun;49(6 Pt 1):1011-4. No abstract available.

24.

Toxicity of free p-cresol: a prospective and cross-sectional analysis.

De Smet R, Van Kaer J, Van Vlem B, De Cubber A, Brunet P, Lameire N, Vanholder R.

Clin Chem. 2003 Mar;49(3):470-8.

25.

The 13C-octanoic acid breath test: validation of a new noninvasive method of measuring gastric emptying in rats.

Schoonjans R, Van Vlem B, Van Heddeghem N, Vandamme W, Vanholder R, Lameire N, Lefebvre R, De Vos M.

Neurogastroenterol Motil. 2002 Jun;14(3):287-93.

PMID:
12061914
26.

In vitro evaluation of motilin agonism by macrolide immunosuppressive drugs.

Van Vlem B, Schoonjans R, Vanholder R, De Vos M, Depoortere I, Peeters TL, Lefebvre R.

Nephrol Dial Transplant. 2002 Jun;17(6):973-7.

PMID:
12032184
27.

An inherited metabolic disorder presenting as ethylene glycol intoxication in a young adult.

Pien K, van Vlem B, van Coster R, Dacremont G, Piette M.

Am J Forensic Med Pathol. 2002 Mar;23(1):96-100.

PMID:
11953504
28.

Gastric emptying of solids in cirrhotic and peritoneal dialysis patients: influence of peritoneal volume load.

Schoonjans R, Van Vlem B, Vandamme W, Van Vlierberghe H, Van Heddeghem N, Van Biesen W, Mast A, Sas S, Vanholder R, Lameire N, De Vos M.

Eur J Gastroenterol Hepatol. 2002 Apr;14(4):395-8.

PMID:
11943952
29.

Dyspepsia and gastroparesis in chronic renal failure: the role of Helicobacter pylori.

Schoonjans R, Van VB, Vandamme W, Van HN, Verdievel H, Vanholder R, Lameire N, De VM.

Clin Nephrol. 2002 Mar;57(3):201-7.

PMID:
11924751
30.

ACE-inhibitors versus angiotensin receptor blockers for renoprotection: conclusions from the evidence and from the evidence behind the evidence.

Van Biesen W, Van Vlem B, Schepkens H, Lameire N.

Acta Clin Belg. 2001 Sep-Oct;56(5):279-83. No abstract available.

PMID:
11770222
31.

Dyspepsia and gastric emptying in chronic renal failure patients.

Van Vlem B, Schoonjans R, Vanholder R, Vandamme W, De Vos M, Lameire N.

Clin Nephrol. 2001 Oct;56(4):302-7.

PMID:
11680660
32.

Blue native polyacrylamide gel electrophoresis: a powerful tool in diagnosis of oxidative phosphorylation defects.

Van Coster R, Smet J, George E, De Meirleir L, Seneca S, Van Hove J, Sebire G, Verhelst H, De Bleecker J, Van Vlem B, Verloo P, Leroy J.

Pediatr Res. 2001 Nov;50(5):658-65.

PMID:
11641463
33.

The Marmara earthquake: epidemiological analysis of the victims with nephrological problems.

Sever MS, Erek E, Vanholder R, Akoğlu E, Yavuz M, Ergin H, Tekçe M, Korular D, Tülbek MY, Keven K, van Vlem B, Lameire N; Marmara Earthquake Study Group.

Kidney Int. 2001 Sep;60(3):1114-23.

34.

[Aspects of kidney donation by living donors].

Van Vlem B, Vermassen F, Hesse U, Van der Vennet M, Vanholder R.

Acta Clin Belg. 2001 Jan-Feb;56(1):17-20. Review. Dutch. No abstract available.

PMID:
11307478
35.

Delayed gastric emptying in dyspeptic chronic hemodialysis patients.

Van Vlem B, Schoonjans R, Vanholder R, De Vos M, Vandamme W, Van Laecke S, Lameire N.

Am J Kidney Dis. 2000 Nov;36(5):962-8.

PMID:
11054352
36.

Continuous ambulatory peritoneal dialysis peritonitis due to Enterococcus cecorum.

De Baere T, Claeys G, Verschraegen G, Devriese LA, Baele M, Van Vlem B, Vanholder R, Dequidt C, Vaneechoutte M.

J Clin Microbiol. 2000 Sep;38(9):3511-2.

37.

A single center's clinical experience with quadruple immunosuppression including ATG or IL2 antibodies and mycophenolate mofetil in simultaneous pancreas-kidney transplants.

Hesse UJ, Troisi R, Jacobs B, Van Vlem B, de Hemptinne B, Van Holder R, Vermassen F, De Roose J, Lameire N.

Clin Transplant. 2000 Aug;14(4 Pt 1):340-4.

PMID:
10945205
38.

Images in clinical medicine. Xanthogranulomatous pyelonephritis.

Van Vlem B, Billiouw JM.

N Engl J Med. 2000 May 25;342(21):1572. No abstract available.

40.

Immunomodulating effects of antibiotics: literature review.

Van Vlem B, Vanholder R, De Paepe P, Vogelaers D, Ringoir S.

Infection. 1996 Jul-Aug;24(4):275-91. Review.

PMID:
8875279
41.

Polyarteritis nodosa and the antiphospholipid syndrome.

Schoonjans R, Van Vlem B, Weyers S, De Keyser F, Praet M, Versieck J, Elewaut A.

Clin Rheumatol. 1996 Jul;15(4):410-3.

PMID:
8853179

Supplemental Content

Loading ...
Support Center